Contemplate the data and tweets to guess whether the closing price of $jnj will surge or decline at 2017-07-18. Please declare either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-07-03,-0.1,0.3,-0.2,0.5,0.5,0.3,1.2,0.9,0.3,-0.3,-1.0
2017-07-05,-0.5,0.3,-0.9,0.6,0.6,-0.4,0.6,0.4,-0.1,-0.7,-1.4
2017-07-06,0.8,1.1,-0.1,-0.8,-0.8,0.2,1.2,1.2,0.8,0.3,-0.4
2017-07-07,0.3,0.3,-0.6,0.0,0.0,0.2,1.0,1.2,0.8,0.4,-0.3
2017-07-10,0.9,1.0,-0.2,-0.7,-0.7,0.8,1.3,1.8,1.6,1.2,0.5
2017-07-11,0.2,0.4,-0.6,-0.2,-0.2,0.8,1.2,1.9,1.8,1.4,0.9
2017-07-12,-0.1,0.5,-0.3,0.8,0.8,-0.2,0.2,1.0,1.1,0.7,0.3
2017-07-13,0.2,0.3,-0.7,-0.3,-0.3,0.0,0.4,1.2,1.3,1.0,0.6
2017-07-14,-0.5,0.3,-0.6,0.6,0.6,-0.5,-0.2,0.4,0.7,0.5,0.2
2017-07-17,0.4,0.6,-0.3,-0.3,-0.3,-0.1,0.1,0.6,1.0,0.9,0.6

2017-07-03: dividend #income update june 2017   $qcom $ibm $blk $wfc $vfc $so $ori $ed $wmt $pfe $tgt $emr $cmi $adm $jnj #stocks|rt AT_USER johnson &amp; johnson #cmo: #innovation needs to sit outside the bottle
2017-07-04: #johnsonjohnson : vaginal mesh risks downplayed by johnson &amp; johnson, court told. read more:  $jnj|monsieur dividende: my june dividend income summary (record!) + latest buys : $pow $enb $jnj $aco
2017-07-05: rt AT_USER johnson &amp; johnson pelvic #mesh: sell, sell, sell !!!! profit over safety! AT_USER $jnj #truth  |rt AT_USER johnson &amp; johnson pelvic #mesh: sell, sell, sell !!!! profit over safety! 
2017-07-06: hey, do you know everything while trading #sp500? $goog $jnj $ge  |who's watching bristol-myers squibb now?  $bmy $mrk $jnj $pfe|options volatility and pricing by sheldon natenberg:  #options #trading
2017-07-07: johnson &amp; johnson $jnj earning somewhat positive press coverage, report finds |johnson &amp; johnson $jnj earning somewhat positive press coverage, report finds |here's why #johnsonjohnson is valu
2017-07-08: AT_USER yes, folks keep asking me for safe div'd paying stocks to park their cash. guess $jnj should be near¡­ |AT_USER today's fray- $jnj AT_USER owner has $40b ibrutinib-who's 1st cousin fails in #p
2017-07-09: analysts set johnson &amp; johnson $jnj pt at $131.01 |analysts set johnson &amp; johnson $jnj pt at $131.01 |analysts set johnson &amp; johnson $jnj pt at $131.01 |analysts set johnson &amp; johnson 
2017-07-10: $jnj 21-jul-17 atm implied volatility is up +4.3%. straddle implies a move of ¡à2.6%. earnings jul 18 bmo. |novartis' ( $nvs ) cosentyx superior to stelara in psoriasis study + news on $amgn $jnj $abb
2017-07-11: biggest cancer drugs of 2022 #stocks $pfe, $mrk, $jnj, $bmy, $celg, $abbv |published $jnj estimate on estimize: ... |#medtech #mergers surge again  $stj $abt $jnj $agn $elos $cutr|rt AT_USER ac immune
2017-07-12: rt AT_USER $jnj releasing earnings on 7/18 before open (confirmed). anybody buying/selling in earnings? |AT_USER $tgtx no reason 1101/ibrutinib should not be approved $abbv $jnj #fda -shorts dangerous
2017-07-13: rt AT_USER fda approves j&amp;j's tremfya to treat psoriasis, to cost about $58,100 per patient annually $jnj |#johnsonjohnson j&amp;j's tremfya gets its go-ahead to fight novartis, lilly in psoriasis
2017-07-14: johnson &amp; johnson $jnj expected to announce earnings of $1.79 per share |johnson &amp; johnson $jnj stock rating lowered by bidaskclub |s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bm
2017-07-15: rt AT_USER #earnings $nflx $bac $msft $gs $blk $jnj $ibm $unh $ge $lmt $v $bx $csx $qcom $hog $pgr $cma $swks $ms $ual $amtd    |rt AT_USER #earnings $nflx $bac $msft $gs $blk $jnj $ibm $unh $ge $lmt 
2017-07-16: rt AT_USER #earnings $nflx $bac $msft $gs $blk $jnj $ibm $unh $ge $lmt $v $bx $qcom $hog  via AT_USER |rt AT_USER #earnings $nflx $bac $msft $gs $blk $jnj $ibm $unh $ge $lmt $v $bx $csx $qcom $hog $pg
2017-07-17: rt AT_USER it's going to be a busy week! earnings galore $nflx $blk $bac $jnj $gs $ual $qcom $gww $axp $abt $msft $v $ebay $nue $s¡­|rt AT_USER upcoming #earnings $nflx $bac $gs $jnj $unh $lmt $hog $p
Answer:
Rise